Other interesting regions are located at 184–257 a.a., representing a domain responsible for the interaction with the partner of BRCA2, the tumor-suppressor PALB2 [48], and at 125–220 a.a., involved in the interaction with p53 [49]. Here, TP53 is linked to neoplasm.